Cargando…

The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials

Recent evidence shows that moxifloxacin could exert an antimicrobial effect against Helicobacter pylori in both in vitro and in vivo models. To systematically evaluate whether moxifloxacin-containing triple therapy could improve eradication rates and reduce side effects in first-line or second-line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, G., Zou, J., Liu, F., Bao, Z., Dong, F., Huang, Y., Yin, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2013
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859334/ https://www.ncbi.nlm.nih.gov/pubmed/23903685 http://dx.doi.org/10.1590/1414-431X20132817

Ejemplares similares

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
por: Zhang, F., et al.
Publicado: (2016)

The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
por: Chung, Kwang Hyun, et al.
Publicado: (2014)

Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection
por: Altun, Battal, et al.
Publicado: (2015)

Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
por: Ahn, Hyo Jun, et al.
Publicado: (2017)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis
por: Mesquita, Priscila Miranda Diogo, et al.
Publicado: (2017)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
por: Kim, Min Soo, et al.
Publicado: (2013)

Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis
por: Lau, Christine S M, et al.
Publicado: (2016)

Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication
por: Sharif, Zain, et al.
Publicado: (2022)

Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection
por: Choi, Jungi, et al.
Publicado: (2006)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
por: Zhang, Zinan, et al.
Publicado: (2023)

Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
por: Eisig, Jaime Natan, et al.
Publicado: (2015)

Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
por: Elkhodary, Noha Mahmoud, et al.
Publicado: (2020)

Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
por: YUAN, YUPING, et al.
Publicado: (2015)

Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials
por: Jiang, Xiaotao, et al.
Publicado: (2018)

Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Mahmoud, Abdelrahman, et al.
Publicado: (2022)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
por: Wu, Meng-Chieh, et al.
Publicado: (2017)

Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
por: Arama, Stefan Sorin, et al.
Publicado: (2016)

Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial
por: Chen, Shasha, et al.
Publicado: (2023)

The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hu, Qian, et al.
Publicado: (2020)

Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies
por: Okimoto, Kenichiro, et al.
Publicado: (2014)

Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis
por: Wang, Zheyu, et al.
Publicado: (2022)

Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study
por: Chotivitayatarakorn, Peranart, et al.
Publicado: (2017)

Rifabutin-Containing Triple Therapy (RHB-105) for Eradication of Helicobacter pylori: Randomized ERADICATE Hp Trial
por: Kalfus, Ira N., et al.
Publicado: (2020)

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
por: Wen, X.J., et al.
Publicado: (2014)

The role of moxifloxacin in tuberculosis therapy
por: Gillespie, Stephen H.
Publicado: (2016)

Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population
por: Shih, Hsiang-Yao, et al.
Publicado: (2012)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
por: Chen, Ming-Cheh, et al.
Publicado: (2014)

Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection
por: Zuniga, Rina, et al.
Publicado: (2015)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection
por: Navarro-Jarabo, José M, et al.
Publicado: (2007)

Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori
por: Chen, Xing Xing, et al.
Publicado: (2022)

A randomized clinical study on the efficacy of vonoprazan combined with amoxicillin duo regimen for the eradication of Helicobacter pylori
por: Yang, Faming, et al.
Publicado: (2023)

The Efficacy of Probiotics in the Management of Helicobacter Pylori: A Systematic Review
por: Penumetcha, Sai Sri, et al.
Publicado: (2021)

Helicobacter pylori and Hepatitis C Virus Coinfection in Egyptian Patients
por: El-Masry, Samir, et al.
Publicado: (2010)

Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?
por: Gong, Eun Jeong, et al.
Publicado: (2014)

The role of Helicobacter pylori infection in functional dyspepsia
por: Rokkas, Theodore
Publicado: (2012)

Helicobacter pylori Infection and Light Chain Gammopathy
por: Girón, José A., et al.
Publicado: (2013)

Gallstones and Concomitant Gastric Helicobacter pylori Infection
por: Attaallah, Wafi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qq9kop57bpa3g1kibfkm4qp5bd